Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pergolide 250microgram tablets
0409010P0AAABAB
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pergolide 50microgram tablets
0409010P0AAAAAA
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pericyazine 2.5mg/5ml oral liquid
0402010P0AAAGAG
|
Pericyazine | Pericyazine | Central Nervous System | No data available |
|
Perphenazine 2mg/5ml oral suspension
0402010Q0AAAKAK
|
Perphenazine | Perphenazine | Central Nervous System | No data available |
|
Perphenazine 4mg/5ml oral suspension
0402010Q0AAALAL
|
Perphenazine | Perphenazine | Central Nervous System | No data available |
|
Pethidine 100mg suppositories
0407020V0AAAUAU
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 100mg/10ml solution for injection ampoules
0407020V0AAALAL
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 100mg/1ml solution for injection ampoules
0407020V0AAAXAX
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 100mg/2ml / Promethazine 50mg/2ml inj ampoules
0407020V0AAAIAI
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 10mg/1ml solution for injection ampoules
0407020V0AAAZAZ
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 10mg/5ml oral solution
0407020V0AABABA
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 25mg/5ml oral solution
0407020V0AAARAR
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 30mg/5ml oral solution
0407020V0AABCBC
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 35mg/5ml oral solution
0407020V0AABEBE
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 40mg/5ml oral solution
0407020V0AABBBB
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 45mg/5ml oral solution
0407020V0AABDBD
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 50mg/5ml oral solution
0407020V0AAATAT
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Pethidine 50mg/5ml solution for injection ampoules
0407020V0AAAPAP
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | No data available |
|
Petinutin 300mg capsules
0408010K0BCAAAA
|
Petinutin | Mesuximide | Central Nervous System | No data available |
|
Peyona 20mg/1ml solution for infusion ampoules
0404000E0BBAAAL
|
Peyona | Caffeine citrate | Central Nervous System | No data available |
|
Phenobarbital 100mg capsules
0408010N0AAASAS
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 100mg tablets
0408010N0AAAMAM
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 10mg capsules
0408010N0AAA7A7
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 12.5mg/5ml oral liquid
0408010N0AADGDG
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 12.6mg/5ml oral liquid
0408010N0AAEPEP
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.